Ian Clark

Ian Clark

Vermogen: 2 M $ op 31-08-2026

65 jaar
Health Technology
Commercial Services
Consumer Non-Durables

Profiel

Mr. Ian T.
Clark
is a Chairman at BioMarin Pharmaceutical, Inc., an Independent Director at Kyverna Therapeutics, Inc., a Chairman at Olema Pharmaceuticals, Inc., a Lead Independent Director at Guardant Health, Inc., a Chairman at X-Vax Technology, Inc. and a Member at TechNet.
He is on the Board of Directors at Asher Biotherapeutics, Inc., Kyverna Therapeutics, Inc. and Guardant Health, Inc. Mr. Clark was previously employed as an Independent Director by GoodRx Holdings, Inc., a Non-Executive Director by Gyroscope Therapeutics Holdings Plc, an Independent Director by Takeda Pharmaceutical Co., Ltd., an Independent Director by Forty Seven LLC, an Independent Director by Tectonic Therapeutic, Inc., an Independent Director by Kite Pharma, Inc., an Independent Director by Corvus Pharmaceuticals, Inc., an Independent Non-Executive Director by Shire Plc, an Independent Director by Agios Pharmaceuticals, Inc., an Independent Director by TerraVia Holdings, Inc., a Chief Executive Officer & Director by Genentech, Inc., a Chief Marketing Officer & Executive Vice President by Roche Group, a General Manager by Novartis Pharmaceuticals Canada, Inc., a Chief Operating Officer by Novartis Pharmaceuticals UK Ltd., a Vice President-Sales by Aventis SA, a Member by Economic Advisory Council, a Vice President-Sales & Marketing by IVAX LLC, a Vice President-Sales by IVAX Pharmaceuticals, Inc., a Vice President-Sales & Marketing by Sanofi, and a Member-BioFulcrum Board by The J.
David Gladstone Institutes.
He also served on the board at Shire Pharmaceuticals, Inc., Dendreon Corp., Dendreon Pharmaceuticals LLC, Biotechnology Innovation Organization, Gladstone Foundation (CA), Ligand UK Ltd., Solazyme, Inc., The Bioindustry Association, Vernalis (R&D) Ltd. and Vernalis Therapeutics, Inc. He received his undergraduate degree from The University of Southampton.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
02-06-2026 14.490 ( 0,01% ) 945 183 $ 31-08-2026
18-03-2026 19.396 ( 0% ) 700 197 $ 31-08-2026
04-08-2026 2.975 ( 0% ) 473 085 $ 31-08-2026
27-05-2026 21.727 ( 0,04% ) 184 136 $ 31-08-2026
20-04-2026 43.100 ( 0,04% ) 150 419 $ 31-08-2026
18-06-2026 0 ( -.--% ) - $ 31-08-2026
11-06-2026 0 ( -.--% ) - $ 31-08-2026

Actieve functies van Ian Clark

BedrijvenFunctieBegin
GUARDANT HEALTH, INC. Directeur/Bestuurslid 01-12-2016
OLEMA PHARMACEUTICALS, INC. Voorzitter 01-08-2020
KYVERNA THERAPEUTICS, INC. Directeur/Bestuurslid 12-01-2026
BIOMARIN PHARMACEUTICAL INC. Voorzitter 02-06-2026
Voorzitter -
Directeur/Bestuurslid 14-02-2022
Corporate Officer/Principal -

Eerdere bekende functies van Ian Clark

BedrijvenFunctieEinde
CORVUS PHARMACEUTICALS, INC. Directeur/Bestuurslid 22-07-2026
TAKEDA PHARMACEUTICAL COMPANY LIMITED Directeur/Bestuurslid 24-06-2026
░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Ian Clark in detail bekijken

Opleiding van Ian Clark

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

81

Eerstegraads connecties

38

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit38

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Non-Durables

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Solazyme, Inc.

Economic Advisory Council

  1. Beurs
  2. Insiders
  3. Ian Clark